Yankees Breathe Easy: Gerrit Cole Spared from Tommy John Surgery
The New York Yankees encountered an ominous start to their season prior to Opening Day when their standout pitcher and reigning AL Cy Young award recipient, Gerrit Cole, reported discomfort in his elbow.
This development sparked apprehension within the organization, as they harbored concerns regarding the well-being of their premier player.
In response to Cole’s discomfort, the Yankees conducted a series of evaluations, including an MRI, amid fears that the right-handed pitcher might have incurred a tear in his ulnar collateral ligament (UCL).
Such an injury would necessitate Tommy John surgery, resulting in his absence for the entirety of the 2024 season and potentially beyond.
Yankees Receive Positive Update on Gerrit Cole’s Injury
As reported by The New York Post, the New York Yankees have received encouraging news following starting pitcher Gerrit Cole’s recent examination with Dr. Neal ElAttrache in Los Angeles.
Fortunately, it has been determined that Cole will not require Tommy John surgery, as there is no evidence of a tear in his ulnar collateral ligament (UCL).
Nevertheless, Cole will still face a significant period of absence from play.
Dr. Neal ElAttrache has recommended a course of rest, rehabilitation, and conservative, non-surgical treatments, which is anticipated to sideline Cole for approximately two months.
Yankees Seek Opening Day Pitcher Amid Cole’s Injury
With the severity of Gerrit Cole’s injury yet to be officially confirmed, the search is underway for a replacement pitcher to take the mound on March 28, marking the Yankees’ first Opening Day without Cole since his arrival in 2019.
Potential candidates for this role include Carlos Rodon and Marcus Stroman, while pitchers such as Cody Morris, Luke Weaver, Luis Gil, and Will Warren are also under consideration to join Nestor Cortes Jr. and Clarke Schmidt.
The Yankees’ inaugural series at Yankee Stadium is scheduled to commence on Friday, April 5, with the Toronto Blue Jays as their opponents.
Comments are closed.